A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.
The population structure of the opportunistic yeast pathogen Candida dubliniensis is composed of three main multilocus sequence typing clades (clades C1 to C3), and clade C3 predominantly consists of isolates from the Middle East that exhibit high-level resistance (MIC(50) > or = 128 microg/ml) to the fungicidal agent flucytosine (5FC). The close relative of C. dubliniensis, C. albicans, also exhibits clade-specific resistance to 5FC, and resistance is most commonly mediated by an Arg101Cys substitution in the FUR1 gene encoding uracil phosphoribosyltransferase. Broth microdilution assays with fluorouracil (5FU), the toxic deaminated form of 5FC, showed that both 5FC-resistant and 5FC-susceptible C. dubliniensis isolates exhibited similar 5FU MICs, suggesting that the C. dubliniensis cytosine deaminase (Fca1p) encoded by C. dubliniensis FCA1 (CdFCA1) may play a role in mediating C. dubliniensis clade-specific 5FC resistance. Amino acid sequence analysis of the CdFCA1 open reading frame (ORF) identified a homozygous Ser29Leu substitution in all 12 5FC-resistant isolates investigated which was not present in any of the 9 5FC-susceptible isolates examined. The tetracycline-inducible expression of the CdFCA1 ORF from a 5FC-susceptible C. dubliniensis isolate in two separate 5FC-resistant clade C3 isolates restored susceptibility to 5FC, demonstrating that the Ser29Leu substitution was responsible for the clade-specific 5FC resistance and that the 5FC resistance encoded by FCA1 genes with the Ser29Leu transition is recessive. Quantitative real-time PCR analysis showed no significant difference in CdFCA1 expression between 5FC-susceptible and 5FC-resistant isolates in either the presence or the absence of subinhibitory concentrations of 5FC, suggesting that the Ser29Leu substitution in the CdFCA1 ORF is the sole cause of 5FC resistance in clade C3 C. dubliniensis isolates.
McManus
Brenda A
BA
Microbiology Research Unit, Division of Oral Biosciences, School of Dental Science and Dublin Dental Hospital, University of Dublin, Trinity College Dublin, Dublin 2, Ireland.
Moran
Gary P
GP
Higgins
Judy A
JA
Sullivan
Derek J
DJ
Coleman
David C
DC
D019943:Amino Acid Substitution; D000935:Antifungal Agents / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects* / Q000201:enzymology; D043525:Cytosine Deaminase / Q000737:chemistry / Q000235:genetics*; D025141:Drug Resistance, Fungal; D005437:Flucytosine / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D013752:Tetracycline / Q000494:pharmacology
D000935:Antifungal Agents; D005437:Flucytosine; D043525:Cytosine Deaminase; D013752:Tetracycline
Mol Microbiol. 1990 Apr;4(4):585-96
2191181
J Clin Microbiol. 2002 Feb;40(2):556-74
11825972
Antimicrob Agents Chemother. 1998 Jul;42(7):1819-30
9661028
Nat Protoc. 2008;3(6):1101-8
18546601
J Oral Pathol Med. 2000 Feb;29(2):86-90
10718404
Nucleic Acids Res. 2001 May 1;29(9):e45
11328886
J Clin Microbiol. 2008 Feb;46(2):652-64
18057125
FEMS Microbiol Lett. 2005 Dec 1;253(1):9-17
16213674
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
7984417
Antimicrob Agents Chemother. 2004 Jun;48(6):2223-7
15155225
Eukaryot Cell. 2007 Jun;6(6):1041-52
17416899
Antimicrob Agents Chemother. 2004 Jan;48(1):262-6
14693548
J Clin Microbiol. 2005 Aug;43(8):4026-36
16081946
J Biol Chem. 2003 May 23;278(21):19111-7
12637534
Curr Genet. 1997 Jan;31(1):1-6
9000374
Antimicrob Agents Chemother. 2005 Aug;49(8):3101-8
16048910
Yeast. 2006 Jul 15;23(9):707-15
16845689
J Clin Microbiol. 2001 Jan;39(1):323-7
11136791
FEMS Yeast Res. 2004 Jan;4(4-5):369-76
14734017
J Clin Microbiol. 1997 Apr;35(4):960-4
9157162
J Clin Microbiol. 1999 Apr;37(4):1035-44
10074523
Eukaryot Cell. 2005 Aug;4(8):1328-42
16087738
J Clin Microbiol. 2000 Jan;38(1):170-4
10618082
J Bacteriol. 2001 May;183(9):2859-65
11292806
Curr Genet. 1999 Sep;36(3):130-6
10501935
Antimicrob Agents Chemother. 2004 Nov;48(11):4377-86
15504867
J Clin Microbiol. 2003 Oct;41(10):4787-9
14532221
Microbiology (Reading). 1995 Jul;141 ( Pt 7):1507-21
7551019
J Clin Microbiol. 1986 Oct;24(4):507-11
3533974
Antimicrob Agents Chemother. 2002 Sep;46(9):2829-41
12183235
J Mol Biol. 1983 Jun 5;166(4):557-80
6345791
J Med Microbiol. 2004 Jul;53(Pt 7):633-637
15184534
Emerg Infect Dis. 2009 Sep;15(9):1467-70
19788816
Antimicrob Agents Chemother. 1984 Oct;26(4):570-4
6393861
Chemotherapy. 1975;21(3-4):113-30
1098864
J Clin Microbiol. 1999 Mar;37(3):870-2
9986880
Antimicrob Agents Chemother. 1983 Jan;23(1):79-85
6338821
Antimicrob Agents Chemother. 2003 Apr;47(4):1275-84
12654658
Genetics. 2008 May;179(1):323-30
18493057
Antimicrob Agents Chemother. 2007 Jan;51(1):369-71
17060521
Antimicrob Agents Chemother. 2009 Jul;53(7):2982-90
19414575
Microbiology (Reading). 2008 Oct;154(Pt 10):3154-3164
18832321